Marksans Pharma gains on UK health regulator nod to market new oral solution
Marksans Pharma received the UK health regulator's nod to market its new oral solution for epilepsy patints.
Source: moneycontrol.com
Stay updated with breaking news from Markans Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marksans Pharma received the UK health regulator's nod to market its new oral solution for epilepsy patints.
MIT's recent investment in Marksans Pharma underscores the small-cap's hidden gem status, fuelled by its strong presence in stable OTC markets and strategic growth initiatives, signalling promising prospects for revenue and profit expansion.